Showing 111-120 of 9243 results for "".
- Abrocitinib Responses Maintained Through Week 72 in JADE REALhttps://practicaldermatology.com/news/abrocitinib-responses-maintained-through-week-72-in-jade-real/2488053/New research suggests that flexible abrocitinib dosing under conditions designed to simulate clinical practice was associated with improvements through Week 72 among observed patients with moderate-to-severe atopic dermatitis (AD). Researchers for the JADE REAL trial enrolled 312 patients
- FDA Approves Tudriqev Plus Nivolumab for Advanced Melanomahttps://practicaldermatology.com/news/fda-approves-tudriqev-plus-nivolumab-for-advanced-melanoma/2488043/The FDA has granted accelerated approval to Tudriqev (vusolimogene oderparepvec-wtpg; Replimune, Inc.) in combination with nivolumab for adults with unresectable advanced cutaneous melanoma whose disease progressed on a programmed death receptor-1 (PD-1)–blocking antibody-based regimen, according
- Study Validates Rapid Screening Tool for Plastic Surgery Meta-analyseshttps://practicaldermatology.com/news/study-validates-rapid-screening-tool-for-plastic-surgery-meta-analyses/2488009/A newly published study suggests that a simple three-question screening tool may help clinicians quickly identify low-quality meta-analyses without relying on lengthy methodological assessments. In a study published in the
- Fractional CO₂ Laser-Assisted Methotrexate Rivals 5-FU in Stable Vitiligohttps://practicaldermatology.com/news/fractional-co-laser-assisted-methotrexate-rivals-5-fu-in-stable-vitiligo/2487990/Topical methotrexate (MTX) delivered through fractional CO₂ laser (FCL) demonstrated efficacy and safety comparable to laser-assisted 5-fluorouracil (5-FU) for stable, nonsegmental vitiligo, according to a study published in Derm
- Meta-Analysis: Comparable Overall Outcomes With Lasers and Chemical Peels for Skin Rejuvenationhttps://practicaldermatology.com/news/meta-analysis-vcomparable-overall-outcomes-with-lasers-and-chemical-peels-for-skin-rejuvenation/2487992/A systematic review and meta-analysis published in Plastic and Reconstructive Surgery found that laser resurfacing and chemical peeling provide comparable overall efficacy for skin rejuvenation, although each modality demon
- Lebrikizumab Meets Primary Endpoints in Phase 3 ADorable-1 Trial for Pediatric Atopic Dermatitishttps://practicaldermatology.com/news/lebrikizumab-meets-primary-endpoints-in-phase-3-adorable-1-trial-for-pediatric-atopic-dermatitis/2487891/Lebrikizumab demonstrated significant improvements in disease severity and symptoms in infants, children, and adolescents with moderate-to-severe atopic dermatitis (AD), according to Week 16 results from the phase 3 ADorable-1 trial presented at the 2026 Society f
- Farming-Associated Maternal Microbiome Linked With Lower Early Childhood Atopic Diseasehttps://practicaldermatology.com/news/study-farming-associated-maternal-microbiome-linked-with-lower-early-childhood-atopic-disease/2487882/A maternal gut microbiome shaped by a traditional farming lifestyle may help explain the protective effect of prenatal farm exposure against atopic disease in children, according to new research published in Allergy.
- Imaging-Guided Tape Stripping Standardizes Molecular Profiling in Pediatric Atopic Dermatitishttps://practicaldermatology.com/news/imaging-guided-tape-stripping-standardizes-molecular-profiling-in-pediatric-atopic-dermatitis/2487887/A minimally invasive, imaging-guided tape-stripping technique may provide a standardized method for molecular profiling and treatment monitoring in pediatric atopic dermatitis (AD), according to findings published online ahead of print in the
- Guideline-Based Management Limits Testing and Identifies Risk Factors for Chronic Urticaria in Childrenhttps://practicaldermatology.com/news/guideline-based-management-limits-testing-and-identifies-risk-factors-for-chronic-urticaria-in-children/2487889/Most children presenting with a first episode of acute urticaria (AU) recover with conservative, guideline-based management and require little diagnostic testing, according to a prospective cohort study published in Pediatric Allergy, Immunology, and Pulmonolog
- Text Messaging Intervention Improves Cardiovascular Risk Behaviors in PsO Trialhttps://practicaldermatology.com/news/text-messaging-intervention-improves-cardiovascular-risk-behaviors-in-pso-trial/2487819/A structured text messaging intervention was shown to improve patient activation and several cardiovascular risk behaviors among adults with psoriasis, according to new findings published in JAMA Dermatology.